InChI=1S/C20H34O3/c1-12(2)14-5-7-19(3)10-15-13(11-21)9-17(22)18(15)20(4,23)8-6-16(14)19/h6,12-15,17-18,21-23H,5,7-11H2,1-4H3/b16-6-/t13-,14+,15+,17+,18-,19+,20-/m0/s1 |
MSKFOQCDNOFJAT-VCRXIKTMSA-N |
[H][C@@]1(CO)C[C@@H](O)[C@]2([H])[C@]1([H])C[C@@]1(C)CC[C@H](C(C)C)\C1=C\C[C@]2(C)O |
|
Streptomyces melanosporofaciens
(NCBI:txid67327)
|
of strain
MI614-43F2
See:
PubMed
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
EC 3.1.1.5 (lysophospholipase) inhibitor
An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of the enzyme lysophospholipase (EC 3.1.1.5), which catalyses the release of fatty acids from lysophospholipids.
|
|
View more via ChEBI Ontology
(1R,3R,3aS,4S,6Z,7R,9aR,10aR)-1-(hydroxymethyl)-4,9a-dimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene-3,4-diol
|
(1R,3R,3aS,4S,6Z,7R,9aR,10aR)-1-(hydroxymethyl)-4,9a-dimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d]cyclooctene-3,4-diol
|
(1R,3R,3aS,4S,6Z,7R,9aR,10aR)-1-(hydroxymethyl)-7-isopropyl-4,9a-dimethyl-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene-3,4-diol
|
IUPAC
|
(1R,3R,3aS,4S,6Z,7R,9aR,10aR)-1-(hydroxymethyl)-7-isopropyl-4,9a-dimethyl-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d]cyclooctene-3,4-diol
|
IUPAC
|
cyclooctatin
|
UniProt
|
31158120
|
Reaxys Registry Number
|
Reaxys
|
1335449
|
PubMed citation
|
Europe PMC
|
1474002
|
PubMed citation
|
Europe PMC
|
19635410
|
PubMed citation
|
Europe PMC
|
25689152
|
PubMed citation
|
Europe PMC
|
26371548
|
PubMed citation
|
Europe PMC
|
26526514
|
PubMed citation
|
Europe PMC
|
26681256
|
PubMed citation
|
Europe PMC
|
28463490
|
PubMed citation
|
Europe PMC
|
|